TFB Advisors LLC lowered its stake in The Cigna Group (NYSE:CI – Free Report) by 12.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 820 shares of the health services provider’s stock after selling 117 shares during the period. TFB Advisors LLC’s holdings in The Cigna Group were worth $226,000 as of its most recent filing with the SEC.
Other hedge funds also recently modified their holdings of the company. International Assets Investment Management LLC raised its position in The Cigna Group by 49,287.7% during the third quarter. International Assets Investment Management LLC now owns 400,040 shares of the health services provider’s stock valued at $138,590,000 after purchasing an additional 399,230 shares in the last quarter. Swedbank AB boosted its holdings in shares of The Cigna Group by 55.1% in the 4th quarter. Swedbank AB now owns 884,406 shares of the health services provider’s stock valued at $244,220,000 after purchasing an additional 314,123 shares in the last quarter. FMR LLC increased its stake in shares of The Cigna Group by 2.0% in the 3rd quarter. FMR LLC now owns 14,230,397 shares of the health services provider’s stock valued at $4,929,978,000 after purchasing an additional 279,880 shares during the last quarter. Raymond James & Associates raised its holdings in shares of The Cigna Group by 42.8% during the 3rd quarter. Raymond James & Associates now owns 860,050 shares of the health services provider’s stock worth $297,956,000 after buying an additional 257,711 shares in the last quarter. Finally, Assenagon Asset Management S.A. lifted its position in shares of The Cigna Group by 68.4% during the 4th quarter. Assenagon Asset Management S.A. now owns 497,875 shares of the health services provider’s stock worth $137,483,000 after buying an additional 202,161 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.
The Cigna Group Price Performance
The Cigna Group stock opened at $292.72 on Thursday. The firm has a market cap of $81.42 billion, a P/E ratio of 23.92, a P/E/G ratio of 0.94 and a beta of 0.54. The stock’s 50 day moving average is $288.17 and its 200 day moving average is $321.82. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72. The Cigna Group has a one year low of $262.03 and a one year high of $370.83.
The Cigna Group Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 20th. Stockholders of record on Wednesday, March 5th will be given a $1.51 dividend. The ex-dividend date is Wednesday, March 5th. This is a positive change from The Cigna Group’s previous quarterly dividend of $1.40. This represents a $6.04 annualized dividend and a dividend yield of 2.06%. The Cigna Group’s dividend payout ratio (DPR) is 45.75%.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on CI shares. Cantor Fitzgerald decreased their target price on The Cigna Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a research report on Friday, January 31st. Royal Bank of Canada decreased their price target on shares of The Cigna Group from $384.00 to $377.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. UBS Group dropped their price objective on shares of The Cigna Group from $410.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, February 3rd. Truist Financial decreased their target price on shares of The Cigna Group from $390.00 to $375.00 and set a “buy” rating on the stock in a research note on Tuesday, February 4th. Finally, Wells Fargo & Company dropped their price target on The Cigna Group from $370.00 to $341.00 and set an “equal weight” rating for the company in a research note on Tuesday, February 4th. Three equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, The Cigna Group currently has an average rating of “Moderate Buy” and a consensus target price of $373.69.
Check Out Our Latest Research Report on CI
About The Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Recommended Stories
- Five stocks we like better than The Cigna Group
- How to Choose Top Rated Stocks
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- Bank Stocks – Best Bank Stocks to Invest In
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.